Butterfly Network

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Butterfly Network reports Q4 growth, seeks CEO for tech scaling

Butterfly Network's Q4 2022 performance showed revenue growth and improved cost management.
The company's strengths lie in democratizing healthcare, international expansion, and cost efficiency.
Challenges include external factors affecting deployments and the ongoing CEO search.
Opportunities for growth include revenue expectations, product developments, and efficiency enhancements.

Butterfly Network reports stable Q1 revenue, eyes AI and home markets

Butterfly Network's Q1 2023 performance showed mixed results with flat revenue but improved margins and reduced EBITDA loss.
The company's strengths in democratizing medical imaging, AI utilization, and strong cash position position it well for future growth.
Challenges include product revenue decline, slower customer growth, and the need to address international distribution weaknesses.
Opportunities in AI, software expansion, home market penetration, and exciting developments offer avenues for future success.

Butterfly Network reports Q2 revenue, focuses on innovation and growth

Butterfly Network's Q2 2023 performance showed mixed results with growth in U.S. sales but a decline in international sales.
The company is leveraging core strengths, launching innovative products, and focusing on revenue growth initiatives.
Challenges include declining international sales and potential impact on current sales due to the upcoming iQ3 launch.
Opportunities lie in new product launches, e-commerce strategy, market expansion, and technology advancements beyond iQ3.

Butterfly Network reports Q3 revenue decline but eyes future growth

Butterfly Network's Q3 2023 performance reflects a strategic shift towards higher-margin offerings and improved operational efficiency.
The company's strengths in revolutionizing ultrasound imaging, education offerings, and partnerships position it for future growth.
Challenges include revenue decline, competitive landscape, and the need for sustained investment in R&D and operational improvements.
Opportunities in upcoming product launches, market expansion, and revenue-sharing agreements present avenues for growth and innovation.

Butterfly Network reports improved Q4 financials and plans expansion

Butterfly Network's financials improved in Q4 2023 with revenue decline but better margins.
Strategic focus on product innovation, global expansion, and revenue growth drivers.
Challenges include revenue decline, EBITDA loss, and potential regulatory impacts.
Opportunities lie in planned growth strategies, resource additions, and lobbying efforts.

Butterfly Network excels in Q1 2024, eyes global expansion

Butterfly Network's Q1 2024 showcased strong revenue growth and operational improvements.
While facing challenges with compliance and financial losses, the company is optimistic about growth.
Strategic priorities and innovative technologies position Butterfly for future success and market expansion.

Butterfly Network reports robust Q2 growth, eyes AI opportunities

Butterfly Network's Q2 performance reflects strong revenue growth, improved cost efficiency, and a positive outlook for the year. The company's strengths in sustainable revenue growth, AI advancements, and strategic partnerships enhance its competitive position. Challenges in regulatory compliance and market expansion require careful navigation, while opportunities in AI, partnerships, and clinical applications offer avenues for growth.

Butterfly Network posts robust Q3 results, eyes tech innovation for growth

Butterfly Network's Q3 2024 performance reflects strong revenue growth, improved profitability, and strategic initiatives for future expansion and innovation.
While facing challenges in managing EBITDA losses and regulatory compliance, the company's financial strength and growth outlook present a positive trajectory.
Opportunities in technological innovation, market expansion, and healthcare initiatives position Butterfly Network for sustained growth and competitive advantage in the industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #ButterflyiQ--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3. The new device is the company's third iteration of the world's first semiconductor-based single-probe, whole-body ultrasound system. Butte.

Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will host one-on-one investor meetings at the 26th Annual Needham Growth Conference on January 16, 2024. To schedule a one-on-one meeting with Joseph DeVivo, Chief Executive Officer, and Heather Getz, Chief Financial and Operations Officer, please reach out to your Needham.

Butterfly to Participate at the 26th Annual Needham Growth Conference

BURLINGTON, Mass. & SAN MATEO, Calif.--(BUSINESS WIRE)---- $BFLY #ButterflyiQ--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Mendaera, a Silicon Valley-based company developing technology to help healthcare providers more easily and confidently perform procedures through the power of medical robotics, today announced an agreement to commercialize a novel robotic system.

Butterfly Network Announces Commercial Agreement with Mendaera for Next-Generation Interventional Robotic System Powered by Butterfly's Ultrasound-on-Chip™ Technology

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the 42nd Annual J.P. Morgan Healthcare Conference taking place January 8-11, 2024, in San Francisco, California. Joseph DeVivo, President & Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will prese.

Butterfly Network to Present at the 42nd Annual J.P. Morgan Healthcare Conference

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the Jefferies London Healthcare Conference taking place on November 14-16, 2023. Joseph DeVivo, Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on November 14, 2023, at 3:30 PM GMT. A live.

Butterfly Network to Present at the Jefferies London Healthcare Conference

Butterfly Network, Inc. (NYSE:BFLY ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Heather Getz - Chief Financial and Operations Officer Joseph DeVivo - Chairman & Chief Executive Officer Conference Call Participants Joshua Jennings - TD Cowen Suraj Kalia - Oppenheimer Operator Hello. Thank you for attending the Butterfly Network Q3 2023 Earnings Call.

Butterfly Network, Inc. (BFLY) Q3 2023 Earnings Call Transcript

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced financial results for the quarter ended September 30, 2023, and provided a business update. Joe DeVivo, Butterfly's Chairman and CEO said, “Butterfly had a productive third quarter as we executed on our strategic plan and near-term initiatives while reducing loss.

Butterfly Network Reports Third Quarter 2023 Financial Results

Butterfly Network, Inc. (BFLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Butterfly Network, Inc. (BFLY) Upgraded to Buy: Here's Why

BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”) (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Forest Neurotech, a deep tech research company that is building a minimally-invasive device for imaging and stimulating the brain with ultrasound, today announced they have entered into a five-year co-development agreement. The agreement includes $20MM to be paid to B.

Butterfly Network Announces 5-Year Co-Development Agreement with Forest Neurotech for Next-generation Brain Computer Interfaces Using Ultrasound-on-Chip™ Technology

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report third quarter 2023 financial results and provide a business update on November 2, 2023, after the market closes. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice-President, and Chief Financial and Operations Officer, will host a.

Butterfly Network, Inc. to Report Third Quarter 2023 Financial Results on November 2, 2023

BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the addition of two new ultrasound education offerings that will complete its full suite of education products. The new offerings will include: Butterfly Certified™, a complete set of virtual and in-person POCUS courses designed to meet local training or.

Butterfly Introduces Two Ultrasound Education Offerings at ACEP23, Demonstrating Value of AI-Guidance and Hands-on Expertise in Driving Mass Ultrasound Adoption

BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Razom, a US-based nonprofit dedicated to supporting a democratic and prosperous Ukraine, today announced that they have expanded their global health partnership to bring an additional 200 Butterfly iQ+ devices to the frontlines of the war in Ukraine. Razom has now alone deployed over 400 Butter.

Butterfly Network and Razom Expand Global Health Partnership To Bring Additional 200 Butterfly iQ+ Ultrasound Systems to Ukraine

BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc., a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, issued a statement on the impact of its comprehensive point-of-care ultrasound (POCUS) solution, Butterfly iQ+, in advancing medical education curriculum nationally. The update follows news from Indiana University School of Medicine (IUSM) earlier this week announcing its investment in Butterfly i.

Butterfly Network Reports Success in Majority of U.S. Medical Schools; Includes Nation's Largest Medical School, Indiana University School of Medicine

Butterfly Network's mission to democratize ultrasound imaging with handheld scanners has not gained widespread adoption. The company's recent Q2/2023 earnings report showed a decline in revenues, and management is guiding for a YoY decline in revenues for the full year. Butterfly Network is pivoting towards artificial intelligence, but it remains uncertain if this will be enough to reset the company's growth trajectory.

Butterfly Network: Will Pivot To AI Be Enough To Restart Growth?

Butterfly Network, Inc. (NYSE:BFLY ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Heather Getz - Executive Vice President & Chief Financial Officer Joseph DeVivo - Chairman & Chief Executive Officer Conference Call Participants Suraj Kalia - Oppenheimer & Co. Neil Chatterji - B. Riley Securities Joshua Jennings - Cowen Danielle Antalffy - UBS Operator Ladies and gentlemen, hello, and welcome to the Butterfly Network Q2 2023 Earnings Call.

Butterfly Network, Inc. (BFLY) Q2 2023 Earnings Call Transcript

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended June 30, 2023, and provided a business update. Highlights Reported total revenue of $18.5 million for the second quarter of 2023, a 3.8% decrease from $19.2 million for the second quarter of 2022, and significantly reduced losses. Conducted a ful.

Butterfly Network Reports Second Quarter 2023 Financial Results

BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the release of its software development kit (SDK) for use by third parties. The SDK can be leveraged by artificial intelligence (AI) software developers, medical device companies building ultrasound into their platforms, and telemedicine companies adding ultrasound into their virtua.

Butterfly Network launches “Butterfly Garden” AI Marketplace for custom AI applications

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2023 financial results and provide a business update on August 3, 2023, before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice-President, and Chief Financial and Operations Officer, will host a.

Butterfly Network, Inc. to Report Second Quarter 2023 Financial Results on August 3, 2023

Apple

Asana

Axonics ModulationTechnologies Inc

Celsius Holdings

Cisco Systems

D.R. Horton

Enphase Energy

Intel

Jiayin Group Inc - ADR

JPMorgan Chase & Co

Coca-Cola

Microsoft

NIKE

Procter & Gamble

Super Micro Computer

UnitedHealth Group

Two new Breakout Stocks for Week 29 with better than 10% short-term upside and a Dow 30 Pick. Average cumulative returns for 2023 are at +126.4% YTD. Last week 3 out of 4 picks gained over 13.4% with peak gains in KODK +23.8%, SMCI +19.2%, YMM +13.4%. The S&P 500 gained +2.4%. The streak of weekly picks gaining over 10% in less than a week has reached 254 out of 320 trading weeks (79.3%) not considering multiple gainers or negative MG signals.

July MDA Breakout Stocks Week 29 - 2023: High-Frequency Gainers To Give You An Edge

Butterfly Network is reinventing itself based on generative AI, which will help develop medical devices and deliver customer service, particularly in training medical professionals in imaging. The company aims to increase its software and subscription revenues, which will improve profitability, and leverage its cloud and AI capabilities for business operations. Butterfly Network could serve as a blueprint for regulated development in the AI field, as it operates under FDA scrutiny and prioritizes data privacy.

Butterfly Network: Favoring Profits And A Possible Blueprint For AI Governance

Butterfly Network, Inc. (NYSE:BFLY ) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Heather Getz - Executive Vice President, Chief Financial Officer Joseph DeVivo - Chairman and CEO Darius Shahida - Chief Strategy Officer Conference Call Participants Joshua Jennings - Cowen Suraj Kalia - Oppenheimer & Co. Neil Chatterji - B. Riley Securities Danielle Antalffy - UBS Operator Ladies and gentlemen, hello and welcome to the Butterfly Network, Inc. Q1 2023 Earnings Call.

Butterfly Network, Inc. (BFLY) Q1 2023 Earnings Call Transcript

Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.22 per share a year ago.

Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Misses Revenue Estimates

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended March 31, 2023, and provided a business update. Highlights Reported total revenue of $15.5 million for the first quarter of 2023, flat to the first quarter ended March 31, 2022. Received FDA clearance of our groundbreaking, AI-enabled Auto B-Line.

Butterfly Network Reports First Quarter 2023 Financial Results

Butterfly Network (BFLY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Butterfly Network (BFLY) Might Surprise This Earnings Season

Butterfly Network Inc. NYSE: BFLY is a medical imaging solutions company that makes point-of-demand portable ultrasound devices to bring medical imaging to healthcare providers at a deep discount to expensive ultrasound machines. Its intended disruption of the ultrasound industry makes it a direct competitor to incumbent ultrasound devices makers like GE Healthcare Technologies Inc. NYSE: GE and Hologic Inc NASDAQ: HOLX.

News for Butterfly Network Stock (BFLY)